Мойзес Веласкес-Манофф - Эпидемия стерильности
- Название:Эпидемия стерильности
- Автор:
- Жанр:
- Издательство:Манн, Иванов и Фербер
- Год:2019
- Город:Москва
- ISBN:978-5-00117-706-7
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Мойзес Веласкес-Манофф - Эпидемия стерильности краткое содержание
Эпидемия стерильности - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
447
T. Jock Murray. “The History of Multiple Sclerosis: The Changing Frame of the Disease over the Centuries”. Journal of the Neurological Sciences 277, Suppl. 1 (2009).
448
Anne-Marie Landtblom et al. “The First Case History of Multiple Sclerosis: Augustus D’Esté (1794–1848)”. Neurological Sciences 31, № 1 (2010).
449
T. Jock Murray. “Robert Carswell: The First Illustrator of MS”. International MS Journal 16 (2009).
450
M. Elian et al. “Multiple Sclerosis Among United Kingdom-born Children of Immigrants from the Indian Subcontinent, Africa and the West Indies”. Journal of Neurology, Neurosurgery, and Psychiatry 53, № 10 (1990).
451
T. Hansen et al. “Concordance for Multiple Sclerosis in Danish Twins: An Update of a Nationwide Study”. Multiple Sclerosis 11, № 5 (2005).
452
U. Leibowitz et al. “Epidemiological Study of Multiple Sclerosis in Israel. II. Multiple Sclerosis and Level of Sanitation”. Journal of Neurology, Neurosurgery, and Psychiatry 29, № 1 (1966).
453
G. Dean. “Annual Incidence, Prevalence, and Mortality of Multiple Sclerosis in White South African-born and in White Immigrants to South Africa”. British Medical Journal 2, № 5554 (1967); G. Dean, J. F. Kurtzke. “On the Risk of Multiple Sclerosis According to Age at Immigration to South Africa”. British Medical Journal 3, № 5777 (1971).
454
W. T. Mayr et al. “Incidence and Prevalence of Multiple Sclerosis in Olmsted County, Minnesota, 1985–2000”. Neurology 61, № 10 (2003).
455
C. Green et al. “A Population-based Ecologic Study of Inflammatory Bowel Disease: Searching for Etiologic Clues”. American Journal of Epidemiology 164, № 7 (2006); K. Kimura et al. “Concurrence of Inflammatory Bowel Disease and Multiple Sclerosis”. Mayo Clinic Proceedings 75, № 8 (2000).
456
John O. Fleming, Thomas D. Cook. “Multiple Sclerosis and the Hygiene Hypothesis”. Neurology 67, № 11 (2006).
457
Jorge Correale, Mauricio Farez. “Association between Parasite Infection and Immune Responses in Multiple Sclerosis”. Annals of Neurology 61, № 2 (2007).
458
M. T. Wallin, A. Heltberg, J. F. Kurtzke. “Multiple Sclerosis in the Faroe Islands. Notifiable Diseases”. Acta Neurologica Scandinavica 122, № 2 (2010).
459
Michael P. Pender. “The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis”. Neuroscientist 17, № 4 (2011); Adam E. Handel et al. “An Updated Meta-analysis of Risk of Multiple Sclerosis Following Infectious Mononucleosis”. PLoS ONE 5, № 9 (2010).
460
S. Haahr et al. “Increased Risk of Multiple Sclerosis after Late Epstein-Barr Virus Infection: A Historical Prospective Study”. Multiple Sclerosis 1, № 2 (1995).
461
Michael J. Goldacre et al. “Multiple Sclerosis after Infectious Mononucleosis: Record Linkage Study”. Journal of Epidemiology & Community Health 58, № 12 (2004).
462
M. A. Hernán et al. “Multiple Sclerosis and Age at Infection with Common Viruses”. Epidemiology 12, № 3 (2001).
463
Sven Haahr, Per Höllsberg. “Multiple Sclerosis Is Linked to Epstein-Barr Virus Infection”. Reviews in Medical Virology 16, № 5 (2006).
464
Sreeram V. Ramagopalan et al. “Geography of Hospital Admissions for Multiple Sclerosis in England and Comparison with the Geography of Hospital Admissions for Infectious Mononucleosis: A Descriptive Study”. Journal of Neurology, Neurosurgery, and Psychiatry 82, № 6 (2011).
465
Hans Lassmann et al. “Epstein-Barr Virus in the Multiple Sclerosis Brain: A Controversial Issue — Report on a Focused Workshop Held in the Centre for Brain Research of the Medical University of Vienna, Austria”. A Journal of Neurology 134, № 9 (2011); Hans Helmut Niller et al. “Epigenetic Dysregulation of Epstein-Barr Virus Latency and Development of Autoimmune Disease”. Advances in Experimental Medicine and Biology 711 (2011).
466
Shanie Saghafan-Hedengren et al. “Early-life EBV Infection Protects against Persistent IgE Sensitization”. Journal of Allergy and Clinical Immunology 125, № 2 (2010).
467
Michel Brahic. “Multiple Sclerosis and Viruses”. Annals of Neurology 68, № 1 (2010).
468
Bent Sørensen. “Demography and the Extinction of European Neanderthals”. Journal of Anthropological Archaeology 30 (2011).
469
L. K. Richman et al. “Novel Endotheliotropic Herpes Viruses Fatal for Asian and African Elephants”. Science 283, № 5405 (1999).
470
Erik S. Barton et al. “Herpes Virus Latency Confers Symbiotic Protection from Bacterial Infection”. Nature 447, № 7142 (2007).
471
Eric J. Yager et al. “Gamma-Herpes Virus-Induced Protection Against Bacterial Infection Is Transient”. Viral Immunology 22, № 1 (2009).
472
Более подробную информацию о полезных вирусах см.: Marilyn J. Roossinck. “The Good Viruses: Viral Mutualistic Symbioses”. Nature Reviews Microbiology 9, № 2 (2011).
473
Luis P. Villarreal. “The Source of Self: Genetic Parasites and the Origin of Adaptive Immunity”. Annals of the New York Academy of Sciences 1178 (2009).
474
L. P. Villarreal. “On Viruses, Sex, and Motherhood” Journal of Virology 71, № 2 (1997).
475
Eriko Maeda et al. “Spectrum of Epstein-Barr Virus-related Diseases: A Pictorial Review”. Japanese Journal of Radiology 27, № 1 (2009).
476
A. Paolillo et al. “The Effect of Bacille Calmette-Guerin on the Evolution of New Enhancing Lesions to Hypointense T1 Lesions in Relapsing Remitting MS”. Journal of Neurology 250, № 2 (2002); G. Ristori et al. “Use of Bacille Calmette-Guerin (BCG) in Multiple Sclerosis”. Neurology 53, № 7 (1999).
477
JangEun Lee et al. “Mycobacteria-induced Suppression of Autoimmunity in the Central Nervous System”. Journal of Neuroimmune Pharmacology 5, № 2 (2010).
478
E. Andersen, H. Isager, K. Hyllested. “Risk Factors in Multiple Sclerosis: Tuberculin Reactivity, Age at Measles Infection, Tonsillectomy and Appendectomy”. Acta Neurologica Scandinavica 63, № 2 (1981).
479
C. R. Gale, C. N. Martyn.“Migrant Studies in Multiple Sclerosis”. Progress in Neurobiology 47, nos. 4–5 (1995).
480
P. Cabre et al. “Role of Return Migration in the Emergence of Multiple Sclerosis in the French West Indies”. Brain 128, № 12 (2005).
481
Jorge Correale, Mauricio F. Farez. “The Impact of Parasite Infections on the Course of Multiple Sclerosis”. Journal of Neuroimmunology 233 (2011).
482
J. Fleming et al. “Probiotic Helminth Administration in Relapsing-remitting Multiple Sclerosis: A Phase 1 Study,” Multiple Sclerosis 17, № 6 (2011).
483
Некоторые отмечают, что в случае появления вакцины от EBV она должна обеспечивать пожизненную защиту. В противном случае, когда в зрелом возрасте действие вакцины закончится, это будет иметь парадоксальные последствия в виде повышения риска развития как инфекционного мононуклеоза, так и рассеянного склероза. Эта глава в значительной мере основана на информации, почерпнутой из: Alberto Ascherio, Kassandra L. Munge. “Epstein-Barr Virus Infection and Multiple Sclerosis: A Review”. Journal of Neuroimmune Pharmacology 5, № 3 (2010).
484
Превосходный обзор идей Эрика Бартона см.: D. W. White, R. Suzanne Beard, E. S. Barton. “Immune Modulation During Latent Herpesvirus Infection”. Immunological Reviews 245, № 1 (2012).
485
Jonathan Silverberg et al. “Chickenpox in Childhood Is Associated with Decreased Atopic Disorders, IgE, Allergic Sensitization, and Leukocyte Subsets”. Pediatric Allergy and Immunology 23, № 1 (February 2012).
486
Betty Diamond et al. “It Takes Guts to Grow a Brain,” BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology 33, № 8 (2011).
487
Лео Каннер. «Аутистические нарушения аффективного контакта». Перевод Виктора Кагана. https://autism-russian.livejournal.com/19209.html. (Leo Kanner. “Autistic Disturbances of Affective Contact”. Nervous Child 2 (1943)) Более подробную информацию о Гансе Аспергере см.: J. H. Baskin, M. Sperber, B. H. Price. “Asperger Syndrome Revisited”. Reviews in Neurological Diseases 3, № 1 (2006).
488
Diagnostic and Statistical Manual of Mental Disorders (англ.), DSM-IV . Прим. пер.
489
S. Ozonoff et al. “A Prospective Study of the Emergence of Early Behavioral Signs of Autism”. Journal of the American Academy of Childhood Adolescent Psychiatry 49, № 3 (2010).
490
Catherine Rice. “Prevalence of Autism Spectrum Disorders — Autism and Developmental Disabilities Monitoring Network, United States, 2006”. Atlanta: Center for Disease Control MMWR, 2009.
491
Данные о расходах в связи с аутизмом взяты из: Michael Ganz. “The Costs of Autism” // Understanding Autism: From Basic Neuroscience to Treatment, ed. Steven O. Moldin and John L. R. Rubenstein. Boca Raton: CRC/Taylor & Frances, 2006.
492
Irva Hertz-Picciotto, Lora Delwiche. “The Rise in Autism and the Role of Age at Diagnosis”. Epidemiology 20, № 1 (2009).
493
A. J. Wakefield et al. “Ileal-lymphoid-nodular Hyperplasia, Non-specific Colitis, and Pervasive Developmental Disorder in Children”. Lancet 351, № 9103 (1998).
494
Frank DeStefano et al. “Age at First Measles-mumps-rubella Vaccination in Children with Autism and School-matched Control Subjects: A Population-based Study in Metropolitan Atlanta”. Pediatrics 113, № 2 (2004).
495
L. Dales et al. “Time Trends in Autism and in MMR Immunization Coverage in California”. JAMA 285, № 9 (2001).
496
В Японии распространенность аутизма выросла почти в четыре раза с 19,6 из 10 000 детей, родившихся в 1988 году, до 81,4 из 10 000 детей, родившихся в 1996 году. Обратите внимание на то, что в абсолютном выражении этот уровень заболеваемости гораздо ниже соответствующего показателя на Западе, так же как и в случае астмы, воспалительных заболеваний кишечника и других иммуноопосредованных заболеваний. Тем не менее, подобно этим заболеваниям, распространенность аутизма неуклонно растет. Hideo Honda, Yasuo Shimizu, Michael Rutter. “No Effect of MMR Withdrawal on the Incidence of Autism: A Total Population Study”. Journal of Child Psychology and Psychiatry, and Allied Disciplines 46, № 6 (2005).
Читать дальшеИнтервал:
Закладка: